OXLUMO works by reducing oxalate production in infants, children, and adults
OXLUMO is a prescription medication for the treatment of primary hyperoxaluria type 1 (PH1) to lower urinary oxalate levels in infants, children, and adults.
CONNECT WITH AN EDUCATOR
Learn about primary hyperoxaluria type 1 (PH1) and treatment with OXLUMO® from one of our trained Alnylam Patient Education Liaisons (PELs).
PELs are employees of Alnylam Pharmaceuticals. They are not acting as healthcare providers and are not part of your healthcare team.